| PERIOD ENDING | 28-Aug-09 | 29-May-09 | 27-Feb-09 | 28-Nov-08 | | Total Revenue | 99,808 | 91,645 | 109,089 | 140,775 | | Cost of Revenue | 78,489 | 73,008 | 85,022 | 114,959 | | | Gross Profit | 21,319 | 18,637 | 24,067 | 25,816 | | | Operating Expenses | | Research Development | 4,755 | 4,478 | 5,142 | 5,436 | | Selling General and Administrative | 13,671 | 13,585 | 13,782 | 14,467 | | Non Recurring |
-
| 989 | 4,141 | 8,096 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,893 | (415) | 1,002 | (2,183) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 111 | 26 | (494) | (163) | | Earnings Before Interest And Taxes | 3,004 | (389) | 508 | (2,346) | | Interest Expense | 1,530 | 1,629 | 1,095 | 2,355 | | Income Before Tax | 1,474 | (2,018) | (587) | (4,701) | | Income Tax Expense | 1,763 | 368 | 1,263 | 2,177 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (289) | (2,386) | (1,850) | (6,878) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (289) | (2,386) | (1,850) | (6,878) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($289) | ($2,386) | ($1,850) | ($6,878) |
|
0.04% Nasdaq 
0.49%
Income Statement
